The identification list of neuropeptides in the DS. The peptides include known neuropeptides, changed peptides, and putative neuropeptides identified using the dual LC-FT-MS/MS approach. PTMS means Δ mass −17.03, pyro-glutamate formation from glutamic acid or glutamine; Δ mass −0.98, amidation. * indicates significantly changed peptides due to chronic nicotine treatment. The sequence of dynorphin A is confirmed using de novo sequencing. § indicates the peptides identified using targeted LC-FT-MS/MS, and # means the peptides identified using directed LC-FT-MS.